Amphotericin B was found to potentiate the antifungal effects of mycophenolic acid glucuronide, tetracycline, and actinomycin D by increasing the penetration of these antibiotics through the fungal cytoplasmic membrane. Because the fungi were over 100 times more susceptible than animal cells to these effects of amphotericin B, these observations might have clinical application. Amphotericin B is a polyene which binds to sterols and changes the permeability properties of yeast and animal cell membranes (5). We have previously used this agent to make yeast cells more susceptible to the action of 5-fluorocytosine and rifampin (6, 7). Here, we report studies of the specificity and nature of the amphotericin B effect.
these observations might have clinical application. Amphotericin B is a polyene which binds to sterols and changes the permeability properties of yeast and animal cell membranes (5) . We have previously used this agent to make yeast cells more susceptible to the action of 5-fluorocytosine and rifampin (6, 7) . Here, we report studies of the specificity and nature of the amphotericin B effect.
In these experiments, we used mycophenolic acid glucuronide, tetracycline, and actinomycin D, all of which inhibit synthesis of specific macromolecules in yeast extracts, but are relatively ineffective against whole cells because of their inability to pass through the cytoplasmic membrane (1, 3) . Amphotericin B made Saccharomyces cerevisiae susceptible to much lower concentrations of these agents by increasing their uptake into the cell, whereas there was no apparent increased uptake of a number of other compounds tested. Also, in the tests performed, the effects of amphotericin B were produced by orders of magnitude less drug with yeast cells than with a human tumor cell line, providing the first evidence that the synergy observed with the drugs might have clinical usefulness. MATERIALS 
RESULTS
Mycophenolic acid inhibited uracil incorporation into RNA in S. cerevisiae MG456, whereas mycophenolic acid glucuronide was completely ineffective (Fig. 1) . The MIC of mycophenolic acid for MG456 was determined to be 10 ,g/ml; in contrast, no effect on cell multiplication was seen with glucuronide concentrations of 250 ,g/ ml ( A, mycophenolic acid, I pg/nml; O, mycophenolic acid, 10 ug/nml; 0, mycophenolic glucuronide, 50 ug/nml; *, mycophenolic acid glucuronide, 100 ,ug/ml. RNA synthesis (Fig. 2) , low levels of mycophenolic acid glucuronide were quite effective in inhibiting yeast RNA synthesis ( Fig. 2 and 3 ). The combination of drugs was synergistic in its effects on colony counts (Table 1) . These effects cannot be attributed to the hydrolysis of the glucuronide: no glucuronidase activity was found either in the culture media or in cell extracts of MG456 (2) .
Tetracycline has been shown to inhibit yeast protein synthesis in cell extracts, but not in whole cells because of its inability to penetrate into the cell (1) . Figure 4 shows that this agent was also made effective against whole cells by low levels of amphotericin B. This result was confirmed by the colony counts, which showed synergy when the drug was used in combination with concentrations of amphotericin B less than half the MIC ( Table 1 ). The effect of tetracycline in this system appeared to be specific, because it inhibited leucine incorporation into protein but did not affect uracil incorporation into RNA (Fig. 4) . Instead, when amphotericin B alone was used at concentrations high enough to result in rapid cell death (10.ug/ml), both protein and RNA synthesis were inhibited simultaneously (data not shown).
Actinomycin D inhibits RNA synthesis in bacteria. Much higher concentrations were ineffective against yeast cells, but again the antibiotic became effective in combination with amphotericin B (Table 1, Fig. 5 ).
The potentiation of antifungal effects of antibiotics by amphotericin B might have clinical applications in the treatment of fungal infections. However, because animal cell membranes also contain sterols, the toxicity of antibiotics to animal cells might be increased by amphotericin B, thereby counteracting the potential benefits of any combined therapy. Figure 6 shows initial studies of the response of RNA synthesis to amphotericin B in S. cerevisiae and in the KB human tumor cell line. At a concentration of 0.5 ,ug/ml, amphotericin B depressed RNA synthesis to 50% ofthe control value in yeast, whereas 100 jig/ml was needed to achieve the same level of inhibition in the human cell line. Thus, the The mechanism of amphotericin B action against fungi is not completely known. The polyene binds to sterols and by this action might cause "holes" in the cytoplasmic membrane of the cell, as it does in model membranes (5 (5) . These studies suggest that the drug combinations employed with yeast may not be toxic to the host, but whole animal experiments must be done to confirm this.
Although the phenomena are very complex, the results suggest that it may be possible to devise, or to find by screening, other agents selective for particular membranes or for the introduction of specific molecules.
